Accordingly, recent studies are developing PSA-based risk models as an aid in the personalized management of the diagnostic workup of PCa, to improve the risk-benefit ratio of the patient, reminding that the ratio of one cancer detected of any grade for every three performed biopsies is ...
PSA testing for cancer screening may help detect prostate cancer early, when it's easier to treat and more likely to be curable. Testing can be done with a simple and widely available blood test. Some people prefer to know one way or the other if they have prostate cancer. ...
Percentage of fPSA contributes to modest diagnostic enhancements above and beyond tPSA alone among men in the “diagnostic gray zone”54. High %fPSA was also shown to be associated with worse survival outcome in patients with biochemical recurrence, indicating that fPSA may have role in progression...
PSA testing for cancer screening may help detect prostate cancer early, when it's easier to treat and more likely to be curable. Testing can be done with a simple and widely available blood test. Some people prefer to know one way or the other if they have prostate cancer. ...
The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with 'atypical glands suspicious for cancer'. Am J Sur Pathol 2011; 35: 608–614. 9 Tomlins SA, Palanisamy N, Siddiqui J, Chinnaiyan AM, Kunju LP. Antibody-based detection of erg rearrangements...
Second, to establish whether measures taken during the diagnostic process could be used to identify those men for whom focal therapy would be a suitable treatment of their prostate cancer. Third, to detail the pathological characteristics of tumours suitable for focal ablation. PATIENTS AND METHODS ...
Proc Natl Acad Sci U S A 91: 11733 – 11737 Midgette AS, Stukel TA, Littenberg B (1993) A meta-analytic method for summarizing diagnostic test performances: receiver-operating-charac- teristic-summary point estimates. Med Decis Making 13: 253 – 257 Nakayama M, Gonzalgo ML, Yegna...
Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur. Urol. 2021, 79, 243–262. [Google Scholar] [CrossRef] [PubMed] El-Sheikh, S.M.; Sheta, S.M.; Salem, S.R.; Abd-Elzaher, M.M.; Basaleh, A.S.; Labib, A.A. Prostate-Specific Antigen Monitoring ...
routine screening in blood for the prostate-specific antigen (PSA), a 28.4 kD serine protease secreted by the epithelial lining of the periurethral glands and the prostatic epithelium, has increased the diagnostic efficiency of prostate cancer from 8% to 18% in less than three decades [3]. Ho...